Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma

doi:10.12998/wjcc.v12.i24.5568

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (446)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-10) series, Tables (1-6) series.

Item

Count

PDF

HTML

249

Figures (1-10)

Tables (1-6)

Sum=368

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=61

Aug 26, 2024 (publication date) through Sep 1, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Aug 26, 2024; 12(24): 5568-5582
Published online Aug 26, 2024. doi: 10.12998/wjcc.v12.i24.5568

Full Size Figure Download Figure

Figure 5 Prognostic model of the risk model. A: Kaplan-Meier curve showed that a higher risk score was associated with poor prognosis; B: Correlation between risk scores in clinical features and hepatocellular carcinoma prognosis. S1 + S2: Stage I and stage II; S3 + S4: Stage III and stage IV. CI: Confidence interval; H: High; HR: Hazard ratio; L: Low; OS: Overall survival.

Citation: Yu TY, Zhan ZJ, Lin Q, Huang ZH. Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma. World J Clin Cases 2024; 12(24): 5568-5582
URL: https://www.wjgnet.com/2307-8960/full/v12/i24/5568.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i24.5568